An underground economy for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Investigational Drug Gaining Popularity Online
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are urged to contact these accounts directly for supplier links, while also obtaining discount codes.
Active Commerce on Social Networks
Additionally, a robust market exists on Telegram, where groups with numerous of participants share comparison images, injection guides and assertions of next-day UK delivery. Sellers promote the drug there before directing customers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Experts Express Concerns
However, physicians and pharmacists have warned that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could result in users administering substances of uncertain source.
Some professionals said the popularity for the experimental drug could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.
Regulatory Position and Implementation
Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Some influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or imprisonment.
Platform Response and Material Removal
Based on TikTok, the service has taken down problematic material and banned associated hashtags and query recommendations. The company stated it was committed to keeping the platform secure and investing in enhancing enforcement strategies.
Online Trading Activities
Investigations also found groups with up to 9,000 participants selling retatrutide using the platform's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of members, populated with images of weight loss, glowing reviews and step-by-step guides for mixing or administering at home.
Within minutes of joining one community, a seller shared contact information, where most transactions take place. The vendor provided an guidebook and promised shipping within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about body mass, health issues or previous experience.
Product Information and Pricing
Within these communities, posts display black plastic packages with postal service labels, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When questioned how long a injector should be used, vendors give conflicting answers varying between a several days to “depends on your body”.
Service Moderation and Security Measures
A spokesperson for Telegram said it actively moderated harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are administering substances they can’t verify. Even if the science behind retatrutide is valid, these digital versions may not include what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in interest to current price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to social media. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.
Her staff has previously encountered patients harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”
Producer Position
A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a company investigational product not yet approved … may subject users to potentially serious health risks”.
